Literature DB >> 11847593

Lack of nitric oxide synthase type 2 (NOS2) results in reduced neuronal apoptosis and mortality following mouse hepatitis virus infection of the central nervous system.

Benjamin P Chen1, Thomas E Lane.   

Abstract

The role of nitric oxide synthase type-2 (NOS2)-derived nitric oxide (NO) in the pathogenesis of mouse hepatitis virus (MHV)-induced central nervous system disease was examined. Infection of NOS2 knockout ((-/-)) and NOS2(+/+) mice with MHV resulted in similar kinetics of viral clearance from the brain and comparable levels of demyelination. MHV-infected NOS2(-/-) mice displayed a marked decrease in mortality as compared to infected NOS2(+/+) mice that correlated with a significant decrease (P < or = 0.001) in the number of apoptotic cells (determined by TUNEL staining) present in the brain. Confocal microscopy revealed that the majority of cells (>70%) undergoing apoptosis were neurons. These studies indicate that NOS2-generated NO contributes to apoptosis of neurons but not demyelination following MHV infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11847593      PMCID: PMC7094997          DOI: 10.1080/135502802317247820

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  37 in total

1.  Activation of CPP32 during apoptosis of neurons and astrocytes.

Authors:  R W Keane; A Srinivasan; L M Foster; M P Testa; T Ord; D Nonner; H G Wang; J C Reed; D E Bredesen; C Kayalar
Journal:  J Neurosci Res       Date:  1997-04-15       Impact factor: 4.164

2.  Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus.

Authors:  T E Lane; A D Paoletti; M J Buchmeier
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Inhibition of Bax channel-forming activity by Bcl-2.

Authors:  B Antonsson; F Conti; A Ciavatta; S Montessuit; S Lewis; I Martinou; L Bernasconi; A Bernard; J J Mermod; G Mazzei; K Maundrell; F Gambale; R Sadoul; J C Martinou
Journal:  Science       Date:  1997-07-18       Impact factor: 47.728

4.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

5.  Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence.

Authors:  R G Dalziel; P W Lampert; P J Talbot; M J Buchmeier
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

6.  Exacerbation of lymphocytic choriomeningitis in mice treated with the inducible nitric oxide synthase inhibitor aminoguanidine.

Authors:  I L Campbell
Journal:  J Neuroimmunol       Date:  1996-12       Impact factor: 3.478

7.  Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler's virus infection.

Authors:  J W Rose; K E Hill; Y Wada; C I Kurtz; I Tsunoda; R S Fujinami; A H Cross
Journal:  J Neuroimmunol       Date:  1998-01       Impact factor: 3.478

8.  Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase.

Authors:  G Karupiah; Q W Xie; R M Buller; C Nathan; C Duarte; J D MacMicking
Journal:  Science       Date:  1993-09-10       Impact factor: 47.728

9.  Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2).

Authors:  H Adler; J L Beland; N C Del-Pan; L Kobzik; J P Brewer; T R Martin; I J Rimm
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

10.  Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus.

Authors:  N Sun; D Grzybicki; R F Castro; S Murphy; S Perlman
Journal:  Virology       Date:  1995-11-10       Impact factor: 3.616

View more
  12 in total

Review 1.  Neurovirological methods and their applications.

Authors:  P G E Kennedy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

Review 2.  Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2.

Authors:  Joy D Iroegbu; Chibuzor W Ifenatuoha; Omamuyovwi M Ijomone
Journal:  Neurol Sci       Date:  2020-05-18       Impact factor: 3.307

3.  Reovirus infection of the CNS enhances iNOS expression in areas of virus-induced injury.

Authors:  Robin J Goody; Cristen C Hoyt; Kenneth L Tyler
Journal:  Exp Neurol       Date:  2005-10       Impact factor: 5.330

4.  Mouse hepatitis virus infection of the CNS: a model for defense, disease, and repair.

Authors:  Chris S Schaumburg; Katherine S Held; Thomas E Lane
Journal:  Front Biosci       Date:  2008-05-01

5.  CXCR2 signaling and host defense following coronavirus-induced encephalomyelitis.

Authors:  Brett S Marro; Martin P Hosking; Thomas E Lane
Journal:  Future Virol       Date:  2012-04       Impact factor: 1.831

Review 6.  Virus infection, antiviral immunity, and autoimmunity.

Authors:  Daniel R Getts; Emily M L Chastain; Rachael L Terry; Stephen D Miller
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

7.  Exacerbated pathology of viral encephalitis in mice with central nervous system-specific autoantibodies.

Authors:  Renaud Burrer; Michael J Buchmeier; Tom Wolfe; Joey P C Ting; Ralph Feuer; Antonio Iglesias; Matthias G von Herrath
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

8.  HCoV-OC43-induced apoptosis of murine neuronal cells.

Authors:  Hélène Jacomy; Pierre J Talbot
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

9.  Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice.

Authors:  Hélène Jacomy; Gabriela Fragoso; Guillermina Almazan; Walter E Mushynski; Pierre J Talbot
Journal:  Virology       Date:  2006-03-09       Impact factor: 3.616

10.  Tempol ameliorates murine viral encephalomyelitis by preserving the blood-brain barrier, reducing viral load, and lessening inflammation.

Authors:  Maria Heloisa Tsuhako; Ohara Augusto; Edlaine Linares; Gerson Chadi; Selma Giorgio; Carlos A Pereira
Journal:  Free Radic Biol Med       Date:  2009-12-24       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.